Liver Failure Therapeutics and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Liver Failure Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Liver Failure Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Liver Failure Therapeutics Overall Market Size
2.1 Global Liver Failure Therapeutics Market Size: 2023 VS 2030
2.2 Global Liver Failure Therapeutics Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Liver Failure Therapeutics Players in Global Market
3.2 Top Global Liver Failure Therapeutics Companies Ranked by Revenue
3.3 Global Liver Failure Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Liver Failure Therapeutics Companies in Global Market, by Revenue in 2023
3.5 Global Companies Liver Failure Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Liver Failure Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Liver Failure Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Liver Failure Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Liver Failure Therapeutics Market Size Markets, 2023 & 2030
4.1.2 Ornithine Phenylacetate
4.1.3 MTL-CEBPA
4.1.4 F-573
4.1.5 BL-1220
4.1.6 PP-100
4.1.7 Others
4.2 By Type - Global Liver Failure Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Liver Failure Therapeutics Revenue, 2019-2024
4.2.2 By Type - Global Liver Failure Therapeutics Revenue, 2025-2030
4.2.3 By Type - Global Liver Failure Therapeutics Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Liver Failure Therapeutics Market Size, 2023 & 2030
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application - Global Liver Failure Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Liver Failure Therapeutics Revenue, 2019-2024
5.2.2 By Application - Global Liver Failure Therapeutics Revenue, 2025-2030
5.2.3 By Application - Global Liver Failure Therapeutics Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Liver Failure Therapeutics Market Size, 2023 & 2030
6.2 By Region - Global Liver Failure Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Liver Failure Therapeutics Revenue, 2019-2024
6.2.2 By Region - Global Liver Failure Therapeutics Revenue, 2025-2030
6.2.3 By Region - Global Liver Failure Therapeutics Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Liver Failure Therapeutics Revenue, 2019-2030
6.3.2 US Liver Failure Therapeutics Market Size, 2019-2030
6.3.3 Canada Liver Failure Therapeutics Market Size, 2019-2030
6.3.4 Mexico Liver Failure Therapeutics Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Liver Failure Therapeutics Revenue, 2019-2030
6.4.2 Germany Liver Failure Therapeutics Market Size, 2019-2030
6.4.3 France Liver Failure Therapeutics Market Size, 2019-2030
6.4.4 U.K. Liver Failure Therapeutics Market Size, 2019-2030
6.4.5 Italy Liver Failure Therapeutics Market Size, 2019-2030
6.4.6 Russia Liver Failure Therapeutics Market Size, 2019-2030
6.4.7 Nordic Countries Liver Failure Therapeutics Market Size, 2019-2030
6.4.8 Benelux Liver Failure Therapeutics Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Liver Failure Therapeutics Revenue, 2019-2030
6.5.2 China Liver Failure Therapeutics Market Size, 2019-2030
6.5.3 Japan Liver Failure Therapeutics Market Size, 2019-2030
6.5.4 South Korea Liver Failure Therapeutics Market Size, 2019-2030
6.5.5 Southeast Asia Liver Failure Therapeutics Market Size, 2019-2030
6.5.6 India Liver Failure Therapeutics Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Liver Failure Therapeutics Revenue, 2019-2030
6.6.2 Brazil Liver Failure Therapeutics Market Size, 2019-2030
6.6.3 Argentina Liver Failure Therapeutics Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Liver Failure Therapeutics Revenue, 2019-2030
6.7.2 Turkey Liver Failure Therapeutics Market Size, 2019-2030
6.7.3 Israel Liver Failure Therapeutics Market Size, 2019-2030
6.7.4 Saudi Arabia Liver Failure Therapeutics Market Size, 2019-2030
6.7.5 UAE Liver Failure Therapeutics Market Size, 2019-2030
7 Liver Failure Therapeutics Companies Profiles
7.1 Alfact Innovation
7.1.1 Alfact Innovation Company Summary
7.1.2 Alfact Innovation Business Overview
7.1.3 Alfact Innovation Liver Failure Therapeutics Major Product Offerings
7.1.4 Alfact Innovation Liver Failure Therapeutics Revenue in Global Market (2019-2024)
7.1.5 Alfact Innovation Key News & Latest Developments
7.2 BioLineRx Ltd
7.2.1 BioLineRx Ltd Company Summary
7.2.2 BioLineRx Ltd Business Overview
7.2.3 BioLineRx Ltd Liver Failure Therapeutics Major Product Offerings
7.2.4 BioLineRx Ltd Liver Failure Therapeutics Revenue in Global Market (2019-2024)
7.2.5 BioLineRx Ltd Key News & Latest Developments
7.3 Cell2B Advanced Therapeutics SA
7.3.1 Cell2B Advanced Therapeutics SA Company Summary
7.3.2 Cell2B Advanced Therapeutics SA Business Overview
7.3.3 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Major Product Offerings
7.3.4 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Revenue in Global Market (2019-2024)
7.3.5 Cell2B Advanced Therapeutics SA Key News & Latest Developments
7.4 Conatus Pharmaceuticals Inc
7.4.1 Conatus Pharmaceuticals Inc Company Summary
7.4.2 Conatus Pharmaceuticals Inc Business Overview
7.4.3 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Major Product Offerings
7.4.4 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Revenue in Global Market (2019-2024)
7.4.5 Conatus Pharmaceuticals Inc Key News & Latest Developments
7.5 Immune Pharmaceuticals Inc
7.5.1 Immune Pharmaceuticals Inc Company Summary
7.5.2 Immune Pharmaceuticals Inc Business Overview
7.5.3 Immune Pharmaceuticals Inc Liver Failure Therapeutics Major Product Offerings
7.5.4 Immune Pharmaceuticals Inc Liver Failure Therapeutics Revenue in Global Market (2019-2024)
7.5.5 Immune Pharmaceuticals Inc Key News & Latest Developments
7.6 Mina Therapeutics Ltd
7.6.1 Mina Therapeutics Ltd Company Summary
7.6.2 Mina Therapeutics Ltd Business Overview
7.6.3 Mina Therapeutics Ltd Liver Failure Therapeutics Major Product Offerings
7.6.4 Mina Therapeutics Ltd Liver Failure Therapeutics Revenue in Global Market (2019-2024)
7.6.5 Mina Therapeutics Ltd Key News & Latest Developments
7.7 Mylan NV
7.7.1 Mylan NV Company Summary
7.7.2 Mylan NV Business Overview
7.7.3 Mylan NV Liver Failure Therapeutics Major Product Offerings
7.7.4 Mylan NV Liver Failure Therapeutics Revenue in Global Market (2019-2024)
7.7.5 Mylan NV Key News & Latest Developments
7.8 Ocera Therapeutics Inc
7.8.1 Ocera Therapeutics Inc Company Summary
7.8.2 Ocera Therapeutics Inc Business Overview
7.8.3 Ocera Therapeutics Inc Liver Failure Therapeutics Major Product Offerings
7.8.4 Ocera Therapeutics Inc Liver Failure Therapeutics Revenue in Global Market (2019-2024)
7.8.5 Ocera Therapeutics Inc Key News & Latest Developments
7.9 PledPharma AB
7.9.1 PledPharma AB Company Summary
7.9.2 PledPharma AB Business Overview
7.9.3 PledPharma AB Liver Failure Therapeutics Major Product Offerings
7.9.4 PledPharma AB Liver Failure Therapeutics Revenue in Global Market (2019-2024)
7.9.5 PledPharma AB Key News & Latest Developments
7.10 Promethera Biosciences SA
7.10.1 Promethera Biosciences SA Company Summary
7.10.2 Promethera Biosciences SA Business Overview
7.10.3 Promethera Biosciences SA Liver Failure Therapeutics Major Product Offerings
7.10.4 Promethera Biosciences SA Liver Failure Therapeutics Revenue in Global Market (2019-2024)
7.10.5 Promethera Biosciences SA Key News & Latest Developments
7.11 Silence Therapeutics Plc
7.11.1 Silence Therapeutics Plc Company Summary
7.11.2 Silence Therapeutics Plc Business Overview
7.11.3 Silence Therapeutics Plc Liver Failure Therapeutics Major Product Offerings
7.11.4 Silence Therapeutics Plc Liver Failure Therapeutics Revenue in Global Market (2019-2024)
7.11.5 Silence Therapeutics Plc Key News & Latest Developments
7.12 Unicyte AG
7.12.1 Unicyte AG Company Summary
7.12.2 Unicyte AG Business Overview
7.12.3 Unicyte AG Liver Failure Therapeutics Major Product Offerings
7.12.4 Unicyte AG Liver Failure Therapeutics Revenue in Global Market (2019-2024)
7.12.5 Unicyte AG Key News & Latest Developments
7.13 Ventria Bioscience
7.13.1 Ventria Bioscience Company Summary
7.13.2 Ventria Bioscience Business Overview
7.13.3 Ventria Bioscience Liver Failure Therapeutics Major Product Offerings
7.13.4 Ventria Bioscience Liver Failure Therapeutics Revenue in Global Market (2019-2024)
7.13.5 Ventria Bioscience Key News & Latest Developments
7.14 Vital Therapies Inc
7.14.1 Vital Therapies Inc Company Summary
7.14.2 Vital Therapies Inc Business Overview
7.14.3 Vital Therapies Inc Liver Failure Therapeutics Major Product Offerings
7.14.4 Vital Therapies Inc Liver Failure Therapeutics Revenue in Global Market (2019-2024)
7.14.5 Vital Therapies Inc Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Liver Failure Therapeutics Market Opportunities & Trends in Global Market
Table 2. Liver Failure Therapeutics Market Drivers in Global Market
Table 3. Liver Failure Therapeutics Market Restraints in Global Market
Table 4. Key Players of Liver Failure Therapeutics in Global Market
Table 5. Top Liver Failure Therapeutics Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Liver Failure Therapeutics Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Liver Failure Therapeutics Revenue Share by Companies, 2019-2024
Table 8. Global Companies Liver Failure Therapeutics Product Type
Table 9. List of Global Tier 1 Liver Failure Therapeutics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Liver Failure Therapeutics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Liver Failure Therapeutics Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Liver Failure Therapeutics Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Liver Failure Therapeutics Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Liver Failure Therapeutics Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Liver Failure Therapeutics Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Liver Failure Therapeutics Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Liver Failure Therapeutics Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Liver Failure Therapeutics Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Liver Failure Therapeutics Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Liver Failure Therapeutics Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Liver Failure Therapeutics Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Liver Failure Therapeutics Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Liver Failure Therapeutics Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Liver Failure Therapeutics Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Liver Failure Therapeutics Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Liver Failure Therapeutics Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Liver Failure Therapeutics Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Liver Failure Therapeutics Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Liver Failure Therapeutics Revenue, (US$, Mn), 2025-2030
Table 30. Alfact Innovation Company Summary
Table 31. Alfact Innovation Liver Failure Therapeutics Product Offerings
Table 32. Alfact Innovation Liver Failure Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 33. Alfact Innovation Key News & Latest Developments
Table 34. BioLineRx Ltd Company Summary
Table 35. BioLineRx Ltd Liver Failure Therapeutics Product Offerings
Table 36. BioLineRx Ltd Liver Failure Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 37. BioLineRx Ltd Key News & Latest Developments
Table 38. Cell2B Advanced Therapeutics SA Company Summary
Table 39. Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Product Offerings
Table 40. Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 41. Cell2B Advanced Therapeutics SA Key News & Latest Developments
Table 42. Conatus Pharmaceuticals Inc Company Summary
Table 43. Conatus Pharmaceuticals Inc Liver Failure Therapeutics Product Offerings
Table 44. Conatus Pharmaceuticals Inc Liver Failure Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 45. Conatus Pharmaceuticals Inc Key News & Latest Developments
Table 46. Immune Pharmaceuticals Inc Company Summary
Table 47. Immune Pharmaceuticals Inc Liver Failure Therapeutics Product Offerings
Table 48. Immune Pharmaceuticals Inc Liver Failure Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 49. Immune Pharmaceuticals Inc Key News & Latest Developments
Table 50. Mina Therapeutics Ltd Company Summary
Table 51. Mina Therapeutics Ltd Liver Failure Therapeutics Product Offerings
Table 52. Mina Therapeutics Ltd Liver Failure Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 53. Mina Therapeutics Ltd Key News & Latest Developments
Table 54. Mylan NV Company Summary
Table 55. Mylan NV Liver Failure Therapeutics Product Offerings
Table 56. Mylan NV Liver Failure Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 57. Mylan NV Key News & Latest Developments
Table 58. Ocera Therapeutics Inc Company Summary
Table 59. Ocera Therapeutics Inc Liver Failure Therapeutics Product Offerings
Table 60. Ocera Therapeutics Inc Liver Failure Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 61. Ocera Therapeutics Inc Key News & Latest Developments
Table 62. PledPharma AB Company Summary
Table 63. PledPharma AB Liver Failure Therapeutics Product Offerings
Table 64. PledPharma AB Liver Failure Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 65. PledPharma AB Key News & Latest Developments
Table 66. Promethera Biosciences SA Company Summary
Table 67. Promethera Biosciences SA Liver Failure Therapeutics Product Offerings
Table 68. Promethera Biosciences SA Liver Failure Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 69. Promethera Biosciences SA Key News & Latest Developments
Table 70. Silence Therapeutics Plc Company Summary
Table 71. Silence Therapeutics Plc Liver Failure Therapeutics Product Offerings
Table 72. Silence Therapeutics Plc Liver Failure Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 73. Silence Therapeutics Plc Key News & Latest Developments
Table 74. Unicyte AG Company Summary
Table 75. Unicyte AG Liver Failure Therapeutics Product Offerings
Table 76. Unicyte AG Liver Failure Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 77. Unicyte AG Key News & Latest Developments
Table 78. Ventria Bioscience Company Summary
Table 79. Ventria Bioscience Liver Failure Therapeutics Product Offerings
Table 80. Ventria Bioscience Liver Failure Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 81. Ventria Bioscience Key News & Latest Developments
Table 82. Vital Therapies Inc Company Summary
Table 83. Vital Therapies Inc Liver Failure Therapeutics Product Offerings
Table 84. Vital Therapies Inc Liver Failure Therapeutics Revenue (US$, Mn) & (2019-2024)
Table 85. Vital Therapies Inc Key News & Latest Developments
List of Figures
Figure 1. Liver Failure Therapeutics Segment by Type in 2023
Figure 2. Liver Failure Therapeutics Segment by Application in 2023
Figure 3. Global Liver Failure Therapeutics Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Liver Failure Therapeutics Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Liver Failure Therapeutics Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Liver Failure Therapeutics Revenue in 2023
Figure 8. By Type - Global Liver Failure Therapeutics Revenue Market Share, 2019-2030
Figure 9. By Application - Global Liver Failure Therapeutics Revenue Market Share, 2019-2030
Figure 10. By Type - Global Liver Failure Therapeutics Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Liver Failure Therapeutics Revenue Market Share, 2019-2030
Figure 12. By Application - Global Liver Failure Therapeutics Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Liver Failure Therapeutics Revenue Market Share, 2019-2030
Figure 14. By Region - Global Liver Failure Therapeutics Revenue Market Share, 2019-2030
Figure 15. By Country - North America Liver Failure Therapeutics Revenue Market Share, 2019-2030
Figure 16. US Liver Failure Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Liver Failure Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Liver Failure Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Liver Failure Therapeutics Revenue Market Share, 2019-2030
Figure 20. Germany Liver Failure Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 21. France Liver Failure Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Liver Failure Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Liver Failure Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Liver Failure Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Liver Failure Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Liver Failure Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Liver Failure Therapeutics Revenue Market Share, 2019-2030
Figure 28. China Liver Failure Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Liver Failure Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Liver Failure Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Liver Failure Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 32. India Liver Failure Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Liver Failure Therapeutics Revenue Market Share, 2019-2030
Figure 34. Brazil Liver Failure Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Liver Failure Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Liver Failure Therapeutics Revenue Market Share, 2019-2030
Figure 37. Turkey Liver Failure Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Liver Failure Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Liver Failure Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Liver Failure Therapeutics Revenue, (US$, Mn), 2019-2030
Figure 41. Alfact Innovation Liver Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. BioLineRx Ltd Liver Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Conatus Pharmaceuticals Inc Liver Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Immune Pharmaceuticals Inc Liver Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Mina Therapeutics Ltd Liver Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Mylan NV Liver Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Ocera Therapeutics Inc Liver Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. PledPharma AB Liver Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Promethera Biosciences SA Liver Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Silence Therapeutics Plc Liver Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Unicyte AG Liver Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Ventria Bioscience Liver Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. Vital Therapies Inc Liver Failure Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)